These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial. Weiss RJ; Stapff M; Lin Y Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546 [TBL] [Abstract][Full Text] [Related]
43. A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes. Sandor GG; Alghamdi MH; Raffin LA; Potts MT; Williams LD; Potts JE; Kiess M; van Breemen C Int J Cardiol; 2015 Jan; 179():470-5. PubMed ID: 25465809 [TBL] [Abstract][Full Text] [Related]
45. Clinical characteristics of normotensive renal transplant recipients with microalbuminuria and effects of angiotensin II type I receptor antagonist on urinary albumin excretion. Satoh S; Horikawa Y; Kakinuma H; Tsuchiya N; Wang L; Kato T; Habuchi T Int J Urol; 2004 Aug; 11(8):585-91. PubMed ID: 15285746 [TBL] [Abstract][Full Text] [Related]
46. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni. El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203 [TBL] [Abstract][Full Text] [Related]
47. Lack of heterologous receptor desensitization induced by angiotensin II type 1 receptor activation in isolated normal rat thoracic aorta. Pérez T; López RM; López P; Castillo C; Castillo EF Vascul Pharmacol; 2011; 54(1-2):29-35. PubMed ID: 21122823 [TBL] [Abstract][Full Text] [Related]
48. Effect of losartan therapy on endothelial function in hypertensive patients. Sosa-Canache B; Hernández-Hernández R; Armas-Padilla MC; Armas-Hernández MJ; Cammarata-Segura R; Pacheco B; Guerrero J; Israili ZH; Valasco M Am J Ther; 2007; 14(2):166-71. PubMed ID: 17414585 [TBL] [Abstract][Full Text] [Related]
49. Effects of losartan + L-arginine on nitric oxide production, endothelial cell function, and hemodynamic variables in patients with heart failure secondary to coronary heart disease. Koifman B; Topilski I; Megidish R; Zelmanovich L; Chernihovsky T; Bykhovsy E; Keren G Am J Cardiol; 2006 Jul; 98(2):172-7. PubMed ID: 16828587 [TBL] [Abstract][Full Text] [Related]
50. [Use of lozartan in patients with chronic cor pulmonale]. Butorov IV; Butorov SI Klin Med (Mosk); 2005; 83(7):65-9. PubMed ID: 16117431 [TBL] [Abstract][Full Text] [Related]
51. The "Rise-Peak-Fall" Pattern of Time Dependency of the Cardiovascular Pleiotropic Effects of Treatment With Low-dose Atorvastatin, Losartan, and a Combination Thereof in Rats. Janic M; Lunder M; Cerne D; Marc J; Jerin A; Skitek M; Drevensek G; Sabovic M J Cardiovasc Pharmacol; 2016 Jul; 68(1):74-80. PubMed ID: 27010807 [TBL] [Abstract][Full Text] [Related]
53. [State of vasoregulative function of vascular endothelium and cardiohemodynamics in patients with chronic obstructive diseases of the lung (CODL) treated with losartan]. Rodionova VV; Lysenko AO; Ruchko VI; Lysenko OA Lik Sprava; 2007; (5-6):111-7. PubMed ID: 18416173 [TBL] [Abstract][Full Text] [Related]